期刊文献+

组织因子与凝血因子在2型糖尿病合并冠心病中的应用价值 被引量:4

下载PDF
导出
摘要 目的探讨组织因子与凝血因子在2型糖尿病合并冠心病中的应用价值。方法测定85例2型糖尿病合并冠心病患者(DM合并冠心病组)、27例无合并症的单纯糖尿病患者(单纯DM组)和21例健康对照者(对照组)血浆组织因子(TF)、凝血因子V(FV)、VIII(FVIII)和VWF活性,以及血小板聚集率(PAR),并分析TF、FV和FVIII与VWF和PAR的相关性。结果 DM合并冠心病组和单纯DM组TF浓度、FV和FVIII活性均显著高于对照组(P<0.001),DM合并冠心病组三者水平显著高于单纯DM组(P<0.01);其中,合并AMI组和合并UAP组TF浓度,FV和FVIII活性均显著高于单纯DM组(P<0.001),并且合并AMI组三者水平显著高于合并UAP组(P<0.01);合并OMI组和合并SAP组TF浓度显著高于单纯DM组(P<0.01),但FV和FVIII活性在3组间无显著差异(P>0.05)。TF浓度、FV和FVIII活性与VWF和PAR水平均呈显著正相关(P<0.01)。结论 TF、FV和FVIII水平增高是2型DM合并冠心病的重要促进因素,TF对评价2型DM合并冠心病患者病情的发展具有重要的意义。
作者 金向红 蒋雷
出处 《海峡药学》 2013年第3期204-206,共3页 Strait Pharmaceutical Journal
  • 相关文献

参考文献8

二级参考文献9

  • 1Camilleri M. Advances in diabetic gastroparesis. Rev Gastroenterol Disord ,2002,2:47.
  • 2Steiner G, Stewart D, Hosking JD, et al. Baseline characteristics of the study population in the Diabetes Atherosclerosis Intervention Study. Am J Cardiol, 1999,84 : 1004-1010.
  • 3O' Donnell J, Mumford A, Manning R, et al. Marked elevation of thrombin generation in partients with elevated plasma factor Ⅷc levels and venous thromboembolium. J Am Hematol,2000 ,96 :268.
  • 4ADVANCE中国区协作组.ADVANCE研究证实强化降糖安全有效[J].中国医学论坛报,2008,34:10-10.
  • 5Monnier L, Mas E, Ginet C,et al. Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes. JAMA ,2006,295 : 1681-1687.
  • 6Saloma V,Stinon V,Byberg L,Kozek E,Katra B,Malecki M,et al.Association of fibrinolytic parameters with early atherosclerosis:The ARIC study[J]. Circulation, 2004, 91 (54): 284-290.
  • 7Staprans I,Rapp JH,Pan X.Oxidized lipid in the diet are a source of oxidized lipid in dylomicrons of human serum[J]. Arterioscler Thromb, 2004, 14 (63) : 1 900-905.
  • 8Mitropoulos KA,Byberg L,Siegbahn A.Autithrombotic effects of rosiglitazonemetformin versus glimepiride-metformin comlination therapy in patients with type 2 diabetes mellitus and metabolic syndrome[J]. Tbromb Res. 2000, 57 ( 82 ) : 541-549.
  • 9Natali A,Toschi E,Bakleweg S,Koh H,Akiyama Y,Yui K ,et al.Clustering of insuliu resistance with vascular dysfunction and low-grade inflammation in type 2 deabetes[J].Diabetes,2006,55(4):1133-140.

共引文献13

同被引文献50

  • 1黄细莲,陈方平,杜建伟,余保军,胡珏,邓满香.血栓性疾病患者血小板相关组织因子水平及活性改变的意义[J].中华内科杂志,2005,44(8):585-587. 被引量:4
  • 2陈文彬.诊断学[M].7版.北京:人民卫生出版社,2008:35-37.
  • 3GIULIARI G P, SADAKA A, CHANG P Y, et al. Diabetic papil- lopathy: current and new treatment options [ J ]. Curr Diabetes Re,, 2011, 7(3) : 171 -175.
  • 4VARMA R, MACIAS G L, TORRES M, et al. Biologic risk fac- tors associated with diabetic retinopathy: the Los Angeles Latino Eye Study[ J]. Ophthalmology, 2007, 114(7) : 1332 - 1340.
  • 5邓红莉.纤维蛋白原、D一二聚体和血管内皮生长因子与糖尿病视网膜病变的关系[J].中外健康文摘,2014,20(5):58.
  • 6KASTHURI R S, GLOVER S L, BOLES J, et al. Tissue factor and issue factor pathway inhibitor as key regulators of global he- mostasis: measurement of their levels in coagulation assays [ J ]. Semin Thromb Hemost, 2010, 36(7): 764 -771.
  • 7PARK K, CHEN Y, HU Y, et al. Nanoparticle -mediated ex- pression of an angiogenic inhibitor ameliorates ischemia - induced retinal neovasculatization and diabetes - induced retinal vascular leakage[J]. Diabetes, 2009, 58(8): 1902- 1913.
  • 8BUTENAS S, BOUCHARD B A, BMMMEL ZIEDINS K E, et al. Tissue factor activity in whole blood[J]. Blood, 2005, 105(7) : 2764 - 2770.
  • 9BRUMMEL ZIEDINS K, UNDAS A, ORFEO T, et al. Thrombio generation in acute coronary syndrome and stable coronary artery disease : Dependence on plasma factor composition [ J ]- J Thromb Haemost, 2008, 6(1 ) : 104 - 110.
  • 10BECKER R C, MAHAFFEY K W, YANG H, et al. Heparin. as- socimed anti - Xa activity and platelet--derived and proin - flam- matoiy biomarkers in moderate to high - risk patients with acute coronary syndrume[ J ] J Thromb Thrombulysis, 2011, 31 ( 2 ) : 146 - 153.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部